Rosemarie Mick
Adjunct Associate Professor of Biostatistics in Biostatistics and Epidemiology
Senior Research Investigator, Department of Biostatistics and Epidemiology, University of Pennsylvania Perelman School of Medicine
Member, Biostatistics Core Facility, Abramson Cancer Center
Adjunct Scholar, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine
Department: Biostatistics and Epidemiology
Contact information
Department of Biostatistics & Epidemiology
University of Pennsylvania Perelman School of Medicine
609 Blockley Hall
423 Guardian Drive
Philadelphia, PA 19104-6021
University of Pennsylvania Perelman School of Medicine
609 Blockley Hall
423 Guardian Drive
Philadelphia, PA 19104-6021
Office: 215 898 9057
Fax: 215 573 4865
Fax: 215 573 4865
Email:
rmick@mail.med.upenn.edu
rmick@mail.med.upenn.edu
Education:
AA
Onondaga Community College, 1974.
BS (Mathematics)
University of Utah , 1980.
MS (Biostatistics)
University of Utah , 1982.
Permanent linkAA
Onondaga Community College, 1974.
BS (Mathematics)
University of Utah , 1980.
MS (Biostatistics)
University of Utah , 1982.
Description of Itmat Expertise
Ms. Mick is interested in the definition of molecular signatures (of genes, proteins or RNA) to sort patients into risk strata. Issues of the development, validation and use of such tools have become central to contemporary clinical cancer research.Selected Publications
Rengen R, Mick R, Pryma D, Rosen M, Lin L, Maity A, Evans T, Stevenson J, Langer C, Kucharczuk J, Friedberg J, Prendergast S, Sharkoski T, Hahn SM.: A phase I trial of the HIV protease inhibitor Nelfinavir with concurrent chemoradiotherapy (CT-RT) for unresectable stage IIIA/IIIB NSCLC: A report of toxicities and metabolic response. Journal of Thoracic Surgery 7: 709-715, 2012.Li Y, Mick R, Heitjan D.: A Bayesian approach for unplanned sample sizes in phase II cancer clinical trials. Clinical Trials 9(3): 293-302, 2012.
Friedberg J, Culligan M, Mick R, Stevenson J, Hahn S, Sterman D, Punekar S, Glatstein E, Cengel K.: Radical pleurectomy and intraoperative photodynamic therapy for malignant pleural mesothelioma. Annals of Thoracic Surgery 93: 1658-1667, 2012.
Sharma A, Koldovsky U, Xu S, Mick R, Roses R, Fitzpatrick E, Weinstein S, Nisenbaum H, Levine BL, Fox K, Zhang P, Koski G, Czerniecki BJ.: HER-2 pulsed dendritic cell vaccine can eliminate HER-2 expression and impact Ductal Carcinoma In Situ. Cancer 118(17): 4354-62, 2012.
Rech A, Mick R, Matin S, Recio A, Aqui N, Powell D, Colligon T, Trosko J, Leinbach L, Pletcher C, Tweed C, DeMichele A, Fox K, Domcheck S, Riley J, Vonderheide R.: CD25 blockade depletes and selectively reprograms regulatory T-cells and cooperates with immunotherapy in cancer patients. Science Translational Medicine 4: 134ra62, 2012.
Wilson J, Krigsfeld G, Sanzari J, Wagner E, Mick R, Kennedy A.: Comparison of hindlimb unloading and partial weight suspension models for spaceflight-type condition induced effects on white blood cells. Advances in Space Research 49: 237-248, 2012.
Koski G, Koldovsky U, Xu S, Mick R, Sharma A, Weinstein S, Nisenbaum H, Levine B, Fox K, Zhang P, Czerniecki B.: A novel dendritic cell-based immunization approach for the induction of duration Th1-polarized anti-HER-2/neu responses in women with early breast cancer. Journal of Immunotherapy 35: 54-65, 2012.
Reshef R, Luger S, Hexner E, Loren A, Frey N, Nasta S, Goldstein S, Stadtmauer E, Smith J, Bailey S, Mick R, Heitjan D, Emerson S, Hoxie J, Vonderheide R, Porter D.: Blockade of Lymphocyte Chemotaxis in Visceral Graft-versus-Host Disease. New England Journal of Medicine 367: 135-145, 2012.
Graves H, Mick R, Sharma A, Lewis R, Roberts S, Fitzpatrick E, Xu S, Zhang P, Czerniecki B.: High surviving expression in ductal carcinoma in situ (DCIS): A potential therapeutic target. Current Cancer Therapy Reviews 8(3): 189-196, 2012.
Harada S, Mick R, Roses RE, Graves H, Niu H, Sharma A, Schueller JE, Nisenbaum H, Czerniecki BJ and Zhang PJ.: The significance of HER-2/neu receptor positivity and immunophenotype in ductal carcinoma in-situ with early invasive disease. Journal of Surgical Oncology 104: 458-465, 2011.